Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT06461910 · RECRUITING

Trial details

NCT number: NCT06461910
Sponsor: Zekuan Xu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Esophagogastric Junction Adenocarcinoma

Start date: 2024-06-14
Primary completion: 2026-01-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.